Published in Mol Pharmacol on July 01, 1982
Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A (2011) 2.44
Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. Br J Pharmacol (1995) 0.86
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse (2001) 4.03
Occupational exposure to the human immunodeficiency virus and other blood-borne pathogens. A six-year prospective study. Med J Aust (1993) 1.81
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug Alcohol Depend (1990) 1.24
Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther (1990) 1.14
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine. J Med Chem (1998) 1.14
Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations. J Clin Microbiol (2003) 1.04
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists. J Med Chem (1998) 1.01
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse (2000) 1.01
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists. J Med Chem (1998) 0.95
HIV infection and international travel. Am Fam Physician (1987) 0.95
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol (2015) 0.94
Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem (2000) 0.92
Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity. Peptides (1994) 0.92
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands. Synapse (1999) 0.91
Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation. J Lipid Res (1981) 0.90
Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist. Proc Natl Acad Sci U S A (1982) 0.88
Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies. Vox Sang (2001) 0.88
Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol (2000) 0.88
Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol (2015) 0.88
Increased sensitivity to epinephrine stimulated lipolysis during starvation: tighter coupling of the adenylate cyclase complex. Biochem Biophys Res Commun (1981) 0.87
Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay. Synapse (1999) 0.87
Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. J Pharmacol Exp Ther (1994) 0.86
Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse (1993) 0.83
Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.83
Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. Brain Res Mol Brain Res (1999) 0.83
Adenylate cyclase of human fat cells. Expression of epinephrrine-sensitive activation revealed by 5'guanylyl-imidodiphosphate. J Clin Invest (1975) 0.82
Adipocyte hormone responsiveness and aging in the rat: problems in the interpretation of aging research. J Am Geriatr Soc (1984) 0.82
Nitrite inhalants: patterns of abuse in Baltimore and Washington, D.C. Am J Drug Alcohol Abuse (1988) 0.81
Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging. Endocrinology (1987) 0.81
Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp Gerontol (1993) 0.81
Human fat cell adenylate cyclase. Enzyme characterization and guanine nucleotide effects on epinephrine responsiveness in cell membranes. Biochim Biophys Acta (1976) 0.81
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci (2000) 0.80
Quantitation of beta adrenergic receptors in rat liver: confounding effect of displaceable but nonstereospecific antagonist binding. J Recept Res (1981) 0.80
Plasma relaxin immunoactivity in the pig at parturition and during nuzzling and suckling. J Reprod Fertil (1979) 0.80
Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides. Peptides (1998) 0.80
Loss of rat ventricular alpha 1-adrenergic receptors during aging. Life Sci (1982) 0.80
HTLV-I associated myelopathy in a Seychellois immigrant. Med J Aust (1993) 0.80
A comparison of the performance of nine commercially available anti-HTLV-I screening assays. J Virol Methods (1993) 0.79
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains. Neurochem Res (1994) 0.79
Endurance training, not acute exercise, differentially alters beta-receptors and cyclase in skeletal fiber types. Am J Physiol (1990) 0.79
Are missionaries at risk for AIDS? Evaluation for HIV antibodies in 3,207 protestant missionaries. South Med J (1989) 0.79
Salts promote activation of fat cell adenylate cyclase by GTP: special role for sodium ion. Proc Natl Acad Sci U S A (1981) 0.78
Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity. Ann N Y Acad Sci (2000) 0.78
Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sites. Peptides (1994) 0.78
Changes in mood, craving and sleep during acute abstinence reported by male cocaine addicts. NIDA Res Monogr (1990) 0.78
(-)[125I]iodopindolol binding to beta-adrenergic receptors in tissues of the rat with particular reference to the characterization in liver. J Recept Res (1986) 0.77
Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. Synapse (1998) 0.77
The (--)[3H]dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of beta-adrenergic sites. J Lipid Res (1982) 0.77
Determinants of the stimulation of fat cell adenylate cyclase by high concentrations of sodium and magnesium salts. Implications for the role of magnesium in regulation of enzyme activity. Biochim Biophys Acta (1980) 0.77
Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology (Berl) (1992) 0.77
Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes. J Pharmacol Exp Ther (1994) 0.77
Essential role of GTP in epinephrine stimulation of human fat cell adenylate cyclase. J Lipid Res (1981) 0.77
Multiple, but not acute, infusions of cocaine alter the release of prolactin in male rats. Brain Res (1990) 0.77
Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes. Regul Pept (1995) 0.76
Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain. Synapse (1991) 0.76
Followup study of possible HIV seropositivity among abusers of parenteral drugs in 1971-72. Public Health Rep (1991) 0.75
Low risk of HIV-1 infection from blood donation: a test-based estimate. Med J Aust (1992) 0.75
If it's the virus why aren't we measuring it? Med J Aust (1996) 0.75
Serological testing algorithms for the diagnosis of HIV infection. AIDS (1999) 0.75
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding. Neurochem Res (1994) 0.75
Nitrite inhalants: contemporary patterns of abuse. NIDA Res Monogr (1988) 0.75
Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain. Peptides (1998) 0.75
Anti-HIV-1 testing results are reported rapidly by Australian laboratories: a national survey. Med J Aust (1992) 0.75
Food restriction prevents an age-associated increase in rat liver beta-adrenergic receptors. J Gerontol (1989) 0.75
Ectopic beta-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. J Clin Endocrinol Metab (1985) 0.75
Acute marijuana smoking reduces vagal tone. NIDA Res Monogr (1990) 0.75
Chronic cocaine administration and withdrawal from cocaine modify central neurotensin receptors in rats. NIDA Res Monogr (1990) 0.75
False-negative results for HIV-1. Med J Aust (1995) 0.75
An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories. Vox Sang (2009) 0.75
Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity. Peptides (1993) 0.75
The distribution of neurophysins and posterior pituitary hormones in the porcine neurohypophyseal system. J Neurochem (1978) 0.75
Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia? HIV Med (2012) 0.75
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors. Synapse (1995) 0.75
Chronic exposure to antibodies directed against anti-opiate peptides alter delta-opioid receptor levels. Peptides (1999) 0.75
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. J Pharmacol Exp Ther (1995) 0.75
Assays for HIV with improved sensitivity and specificity. Expert Opin Investig Drugs (1997) 0.75
Iodate promotes guanosine triphosphate stimulation of human fat-cell adenylate cyclase. Arch Biochem Biophys (1982) 0.75
Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain. Peptides (1995) 0.75
HIV transmission, lab technicians, and open-toed shoes. JAMA (1988) 0.75
Ligand selectivity of cloned human and rat opioid mu receptors. Synapse (1995) 0.75
Blood screening--the next generation in testing. Aust N Z J Med (1999) 0.75
An evaluation of two simple synthetic peptide based anti-HIV assays. J Virol Methods (1992) 0.75
Altered glucagon- and catecholamine hormone-sensitive adenylyl cyclase responsiveness in rat liver membranes induced by manipulation of dietary fatty acid intake. Endocrinology (1990) 0.75
Release and clearance of neurophysins and posterior pituitary hormones. Ann N Y Acad Sci (1975) 0.75
Identification of infection of an Australian resident with the human immunodeficiency virus type 2 (HIV-2). Med J Aust (1992) 0.75
Individual neurophysin concentrations in the pituitary and circulation of humans. Clin Endocrinol (Oxf) (1979) 0.75